ConductScience.org, home
A Study of Atezolizumab in Participants With Programmed Death - Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer
API referenceFor AI assistants

Trial · NCT02031458

Participant flow18

How many started, completed or left each group, period by period.

1 to 18 of 18

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
May 8, 2015 to January 11, 2019STARTEDCohort 1: First Line Atezolizumab138
May 8, 2015 to January 11, 2019STARTEDCohort 2: Second Line Atezolizumab269
May 8, 2015 to January 11, 2019STARTEDCohort 3: Third Line and Beyond Atezolizumab252
May 8, 2015 to January 11, 2019COMPLETEDCohort 1: First Line Atezolizumab0
May 8, 2015 to January 11, 2019COMPLETEDCohort 2: Second Line Atezolizumab0
May 8, 2015 to January 11, 2019COMPLETEDCohort 3: Third Line and Beyond Atezolizumab0
May 8, 2015 to January 11, 2019NOT COMPLETEDCohort 1: First Line Atezolizumab138
May 8, 2015 to January 11, 2019NOT COMPLETEDCohort 2: Second Line Atezolizumab269
May 8, 2015 to January 11, 2019NOT COMPLETEDCohort 3: Third Line and Beyond Atezolizumab252
Baseline to May 8, 2015STARTEDCohort 1: First Line Atezolizumab139
Baseline to May 8, 2015STARTEDCohort 2: Second Line Atezolizumab267
Baseline to May 8, 2015STARTEDCohort 3: Third Line and Beyond Atezolizumab253
Baseline to May 8, 2015COMPLETEDCohort 1: First Line Atezolizumab0
Baseline to May 8, 2015COMPLETEDCohort 2: Second Line Atezolizumab0
Baseline to May 8, 2015COMPLETEDCohort 3: Third Line and Beyond Atezolizumab0
Baseline to May 8, 2015NOT COMPLETEDCohort 1: First Line Atezolizumab139
Baseline to May 8, 2015NOT COMPLETEDCohort 2: Second Line Atezolizumab267
Baseline to May 8, 2015NOT COMPLETEDCohort 3: Third Line and Beyond Atezolizumab253

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02031458/flow

API referenceFor AI assistants